跳至主要内容
临床试验/NCT03068208
NCT03068208已完成不适用

Efficacy of Methylene Blue Mediated Photodynamic Therapy for Primary Localized Cutaneous Amyloidosis Treatment in Asians: Pilot Study

Chulalongkorn University1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2022年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Roughness evaluation by using visioscan

研究概览

简要总结

Efficacy of Methylene blue mediated Photodynamic therapy for primary localized cutaneous amyloidosis treatment in Asians, pilot study.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patients, aged > 18 years old with lichen amyloidosis diagnosed by using clinical presentation and pathological findings.

排除标准

  • •Those with systemic disease associated cutaneous amyloidosis
  • •Pregnancy or lactating woman
  • •Those who are allergic to urea, olive oil
  • •Those who are photosensitive to ultraviolet radiation
  • •Those who had been previously treated with any of which -medications, radiation, laser within 3 months and 1 month for topical therapy

研究组 & 干预措施

Control

No Intervention

MB-PDT

Experimental

干预措施: Methylene blue-mediated photodynamic therapy (Procedure)

结局指标

主要结局

Roughness evaluation by using visioscan

时间窗: Change from baseline roughness at every 2 weeks up to 16 weeks

The improvement of roughness during the treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Einapak Boontaveeyuwat, MD

Asst. Prof.

Chulalongkorn University

研究点 (1)

Loading locations...

相似试验